Search
for
Sort by
Research 601–630 of 1000+
- Drugs and Hair Loss
- Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex
- Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Cetuximab-Associated Elongation of the Eyelashes
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Allopregnanolone promotes proliferation and differential gene expression in human glioblastoma cells
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Genetically modified laboratory mice with sebaceous glands abnormalities
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Trichoscopic Findings of Erosive Pustular Dermatosis of the Scalp Associated with Gefitinib
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Acneiform Eruption with Topical Recombinant Human Epidermal Growth Factor
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Skin toxicity of anti‐cancer therapy
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Perifollicular Xanthomas Associated with Epidermal Growth Factor Receptor Inhibitor Therapy
- Dermatologic Reactions to Targeted Therapy
- Nrf2-Mediated Expansion of Pilosebaceous Cells Accelerates Cutaneous Wound Healing
- Brief Report: Requirement of TACE/ADAM17 for Hair Follicle Bulge Niche Establishment
- Cetuximab-induced hypertrichosis of the scalp and eyelashes
- Management of Dermatologic Toxicities
- Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer
- The epidermal growth factor receptor decreases Stathmin 1 and triggers catagen entry in the mouse
- Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management.
- The Epithelial Stem Cell Niche in Skin
- Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients